[EN] PRODRUGS OF [4[4-(5-AMINOMETHYL-2-FLUORO-PHENYL)-PIPERIDIN-1-YL]-(1H-PYRROLO-PYRIDIN-YL)-METHANONES AND SYNTHESIS THEREOF [FR] PROMÉDICAMENTS DE [4[4-(5-AMINOMÉTHYL-2-FLUORO-PHÉNYL)-PIPÉRIDIN-1-YL]-(1H-PYRROLO-PYRIDIN-YL)-MÉTHANONES ET LEUR SYNTHÈSE
PRODRUGS OF [4 [4-(5-AMINOMETHYL-2-FLUORO-PHENYL)-PIPERIDIN-1-YL]-(1H-PYRROLO-PYRIDIN-YL)-METHANONES AND SYNTHESIS THEREOF
申请人:CHOI-SLEDESKI Yong Mi
公开号:US20120238573A1
公开(公告)日:2012-09-20
The present invention relates to substituted 2-amino-N-(4-fluoro-3-1-[1-(alkyl)-1H-indole-3-carbonyl]-piperidin-4-yl}-benzyl)-acetamides (compounds of formula I)
compositions thereof, and their use in the treatment of inflammatory diseases.
Prodrugs of [4 [4-(5-Aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-(1H-pyrrolo-pyridin-yl)-methanones and synthesis thereof
申请人:Choi-Sledeski Yong Mi
公开号:US08710080B2
公开(公告)日:2014-04-29
The present invention relates to substituted 2-amino-N-(4-fluoro-3-1-[1-(alkyl)-1H-indole-3-carbonyl]-piperidin-4-yl}-benzyl)-acetamides (compounds of formula I)
compositions thereof, and their use in the treatment of inflammatory diseases.
PRODRUGS OF [4[4-(5-AMINOMETHYL-2-FLUORO-PHENYL)-PIPERIDIN-1-YL]-(1H-PYRROLO-PYRIDIN-YL)-METHANONES AND SYNTHESIS THEREOF
申请人:SANOFI
公开号:EP2516418A1
公开(公告)日:2012-10-31
US8710080B2
申请人:——
公开号:US8710080B2
公开(公告)日:2014-04-29
[EN] PRODRUGS OF [4[4-(5-AMINOMETHYL-2-FLUORO-PHENYL)-PIPERIDIN-1-YL]-(1H-PYRROLO-PYRIDIN-YL)-METHANONES AND SYNTHESIS THEREOF<br/>[FR] PROMÉDICAMENTS DE [4[4-(5-AMINOMÉTHYL-2-FLUORO-PHÉNYL)-PIPÉRIDIN-1-YL]-(1H-PYRROLO-PYRIDIN-YL)-MÉTHANONES ET LEUR SYNTHÈSE
申请人:SANOFI SA
公开号:WO2011079095A1
公开(公告)日:2011-06-30
The present invention relates herein to compounds and compositions for the treatment and amelioration of inflammatory disease. Specifically the present invention relates to compounds that having a tryptase inhibition activity and the intermediates thereof, pharmaceutical compositions comprising such compounds, and a method of treating subjects suffering from a condition disease or disorder that can be ameliorated by the administration of an inhibitor of tryptase including but not limited to for example asthma and other inflammatory diseases including acute macular degeneration.